Literature DB >> 12163498

Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells.

Xiaobin Han1, Andrea Budreau Patters, Russell W Chesney.   

Abstract

Taurine, an intracellular osmolyte whose body pool size is adaptively regulated by the kidney, is required for normal renal development. Overexpression of the p53 tumor suppressor gene in p53 transgenic mice results in renal malformation, suggesting that altered expression of certain p53 target gene(s) involved in renal development may be responsible. This study shows that the taurine transporter gene (TauT) is a transcriptional target of p53. Expression of TauT was decreased after activation of p53 by doxorubicin, a DNA-damaging drug, in 293 and NRK-52E renal cells. TauT promoter activity was decreased 5-10-fold by cotransfection of a full-length TauT promoter-reporter construct with p53, which was reversed by cotransfection with a mutant p53 (p53-281). Electrophoretic mobility shift assays using nuclear extracts from p53-expressing (10)1val cells showed a putative p53-binding site in the TauT promoter region, which bound to the p53 in electrophoretic mobility shift assays. Mutation of this p53 consensus sequence abolished binding of p53. These results demonstrate that TauT may represent a downstream target gene of p53 that could link the roles of p53 in renal development and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163498     DOI: 10.1074/jbc.M205939200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  The tumor suppressor p53 inhibits Net, an effector of Ras/extracellular signal-regulated kinase signaling.

Authors:  Koji Nakade; Hong Zheng; Gitali Ganguli; Gilles Buchwalter; Christian Gross; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Myogenic differentiation induces taurine transporter in association with taurine-mediated cytoprotection in skeletal muscles.

Authors:  Yoriko Uozumi; Takashi Ito; Yuki Hoshino; Tomomi Mohri; Makiko Maeda; Kyoko Takahashi; Yasushi Fujio; Junichi Azuma
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

3.  Regulation of TauT by cisplatin in LLC-PK1 renal cells.

Authors:  X Han; R W Chesney
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

4.  Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content.

Authors:  Chian Ju Jong; Takashi Ito; Mahmood Mozaffari; Junichi Azuma; Stephen Schaffer
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 5.  Taurine and the renal system.

Authors:  Russell W Chesney; Xiaobin Han; Andrea B Patters
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

6.  Stress-responsive gene TauT and acute kidney injury.

Authors:  Xiaobin Han; Russell W Chesney
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

7.  Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cells.

Authors:  Takashi Ito; Yasushi Fujio; Mayo Hirata; Tomoka Takatani; Takahisa Matsuda; Satoko Muraoka; Kyoko Takahashi; Junichi Azuma
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

8.  Functional TauT protects against acute kidney injury.

Authors:  Xiaobin Han; Junming Yue; Russell W Chesney
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

Review 9.  Taurine and its chloramine: modulators of immunity.

Authors:  Georgia B Schuller-Levis; Eunkyue Park
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 10.  Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations.

Authors:  M L Tappaz
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.